关注
Shruti Bhandari
Shruti Bhandari
Northern Light Cancer Care-DFCI Collaborative
在 northernlight.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Lung cancer screening rates: data from the lung cancer screening registry.
D Pham, S Bhandari, M Oechsli, CM Pinkston, GH Kloecker
Journal of Clinical Oncology 36 (15_suppl), 6504-6504, 2018
952018
Lung cancer screening registry reveals low-dose CT screening remains heavily underutilized
D Pham, S Bhandari, C Pinkston, M Oechsli, G Kloecker
Clinical lung cancer 21 (3), e206-e211, 2020
942020
“Lost to follow-up” among adult cancer survivors
A Gill, R Gosain, S Bhandari, R Gosain, G Gill, J Abraham, K Miller
American Journal of Clinical Oncology 41 (10), 1024-1027, 2018
292018
Management of immunotherapy toxicities in older adults
S Bhandari, AS Gill, CA Perez, D Jain
Seminars in Oncology 45 (4), 226-231, 2018
252018
Pembrolizumab induced toxic epidermal necrolysis
R Kumar, S Bhandari
Curr Probl Cancer 44 (2), 100478, 2020
222020
Outcomes of hypercalcemia of malignancy in patients with solid cancer: a national inpatient analysis
S Bhandari, R Kumar, P Tripathi, A Chan, S Mudra, R Redman
Medical Oncology 36, 1-6, 2019
212019
Performance of community-based lung cancer screening program in a Histoplasma endemic region
S Bhandari, P Tripathi, D Pham, C Pinkston, G Kloecker
Lung Cancer 136, 102-104, 2019
152019
Assessment of hospitalization rates for immune-related adverse events with immune checkpoint inhibitors
L Nice, R Bycroft, X Wu, SN Rai, L Figg, S Bhandari, M Burd
Journal of Oncology Pharmacy Practice 27 (7), 1736-1742, 2021
142021
The Hispanic paradox in non-small cell lung cancer
R Kumar, F Castillero, S Bhandari, S Malapati, G Kloecker
Hematology/Oncology and Stem Cell Therapy, 2021
142021
Thrombotic thrombocytopenic purpura
S Bhandari, R Kumar
New England Journal of Medicine 380 (16), e23, 2019
142019
Racial differences in development of immune-related adverse events.
S Bhandari, R Kumar, L Nice, A Cheema, GH Kloecker
Journal of Clinical Oncology 38 (15_suppl), e15148-e15148, 2020
102020
Timing of treatment in small-cell lung cancer
S Bhandari, D Pham, C Pinkston, M Oechsli, G Kloecker
Medical Oncology 36, 1-5, 2019
102019
Updated results from a phase I/II study of duvelisib and venetoclax in patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) or Richter's syndrome (RS)
CE Ryan, JL Crombie, S Tyekucheva, MM McDonough, JS Montegaard, ...
Blood 140 (Supplement 1), 9871-9872, 2022
72022
Adherence to anti-estrogen therapy in women with hormone receptor-positive breast cancer utilizing bubble packaging: a pilot study
S Bhandari, P Ngo, B Kute, M Mandadi, WA Pitman, X Wu, S Lloyd, ...
Breast Cancer Research and Treatment 177, 395-399, 2019
72019
Bilateral adrenal hemorrhage in polycythemia vera
S Bhandari, K Agito, EI Krug
Journal of Community Hospital Internal Medicine Perspectives 6 (4), 32416, 2016
72016
Treatment timing in small cell lung cancer, a national cancer database analysis
S Bhandari, R Kumar, D Pham, J Gaskins, G Kloecker
American Journal of Clinical Oncology 43 (5), 362-365, 2020
62020
Radiotherapy in brain metastases from EGFR-mutated non-small cell lung cancer
S Bhandari, N Dunlap, G Kloecker
Journal of Thoracic Disease 13 (5), 3230, 2021
52021
Incidence and outcomes of acute transfusion reactions in hospitalized patients in the United States
R Kumar, S Malapati, SRK Singh, B Mamedov, MR Shah, S Bhandari
Blood 136, 30-31, 2020
42020
Incidence and outcomes of heparin‐induced thrombocytopenia in solid malignancy: an analysis of the national inpatient sample database
R Kumar, S Bhandari, SRK Singh, S Malapati, KI Cisak
British journal of haematology 189 (3), 543-550, 2020
42020
Stereotactic radiosurgery in the era of novel systemic therapy for lung cancer brain metastases
S Mudra, S Bhandari, P Tripathi, N Dunlap, G Kloecker
J Cancer Metastasis Treat 5 (27), 1-9, 2019
42019
系统目前无法执行此操作,请稍后再试。
文章 1–20